Bristol-Myers Squibb Company Blog | Talkmarkets

Latest Posts

Back To The Negotiating Table

Article By: Mati Greenspan

Tuesday, August 27, 2019 8:11 AM EDT

The market focus going into last week was shifting from the US-China trade war to the Fed and the monetary policy of other central banks.

In this article: BITCOMP, DISH, BYND, BMY, WORK, LYFT

Read

Bristol-Myers Passes $74 Bln Deal’s First Big Exam

Article By: Lipper Alpha Insight

Tuesday, August 27, 2019 4:24 AM EDT

Bristol-Myers Squibb boss Giovanni Caforio can heave a sigh of relief. The drugmaker, valued at $76 billion at Friday’s close, is stretching to buy Celgene for almost as much again.

In this article: CELG, BMY

Read

Four High Earnings Yield Stocks To Bolster Your Portfolio

Article By: Zacks Investment Research

Tuesday, August 20, 2019 10:59 AM EDT

If you are not sure whether to invest your money in bonds or stocks, a key parameter that can show you the right direction is earnings yield.

In this article: BMY, CMC, DAL, UAL

Read

Bristol-Myers Squibb Is Undervalued

Article By: Andres Cardenal

Monday, August 19, 2019 4:36 PM EDT

Bristol-Myers Squibb is under considerable pressure, the stock has declined by more than 25% from its highs of the year due to generalized negativity towards the drug manufacturing sector and the uncertainty produced by the Celgene acquisition.

In this article: BMY Also: CELG

Read